cd4 percp cy 5 5 Search Results


98
Revvity percp cy5 5 cd4
Percp Cy5 5 Cd4, supplied by Revvity, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/percp cy5 5 cd4/product/Revvity
Average 98 stars, based on 1 article reviews
percp cy5 5 cd4 - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

90
MD Biosciences anti-cd4-percp-cy5.5
Anti Cd4 Percp Cy5.5, supplied by MD Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd4-percp-cy5.5/product/MD Biosciences
Average 90 stars, based on 1 article reviews
anti-cd4-percp-cy5.5 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Becton Dickinson cd4 (catalog# 550954)
Intravesical adoptive cellular therapy (ACT) using OT-I T cells delays ovalbumin expressing MB49 tumor cell line (MB49OVA) orthotopic tumor growth. Mice were inoculated with orthotopic MB49OVA tumors. Mice were treated with OT-I cells labeled with CellTrace Violet (CTV) delivered intravesically. (A) After 3 hours of instillation, tumors were collected and analyzed for CTV-labeled OT-I T cells by flow cytometry. (B) Mice with MB49OVA orthotopic tumors were treated with unlabeled OT-I T cells and monitored for tumor growth by ultrasound. ACT-treated mice had a reduction in tumor volume compared with phosphate-buffered saline (PBS)-treated mice and improved survival (C). (D) Tumors were collected on day 60 and analyzed for CD3 + , CD8 + , <t>CD4</t> + and CD8 + OVA tetramer + T cells by flow cytometry. (E) Representative ultrasound images from mice in each treatment group −2 days prior to treatment and 44 days post-treatment. N=8 per group. Repeated 3 times.
Cd4 (Catalog# 550954), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd4 (catalog# 550954)/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd4 (catalog# 550954) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Fisher Scientific percp-cy 5.5 mouse anti-human cd4 (cat # bdb560650)
CEM-T4 were mixed in a 1 to 3 ratio with Raw 264.7 cells (± CdCl2) as controls and compared to mixes with CEM-T4 and N5 (± CdCl2). The mixed population of cells were analyzed by flow cytometry for cell surface <t>CD4</t> staining. Representative 2-D scatter plots of the CD4 fluorescence intensity (log scale) in CEM-T4 mixed with N5 (red) vs Raw 264.7 (black) not-treated (a) or treated with CdCl2 for 24 h (b). A downward shift in CD4 fluorescence can be observed between N5 vs Raw 264.7 treated with CdCl2. Representative Cumulative Distribution Function (CDF) (c) and histogram (d) graphs of fluorescence intensity of CD4 (log scale) in CEM-T4 in response to the various co-cultures are plotted. Black line is CD4 negative control (CD4 unlabeled CEM-T4); black dotted line is <t>CD4</t> <t>positive</t> control (CD4 labeled CEM-T4); gray is CEM-T4 transfected with Nef-GFP (control to look at the effect of Nef expression on CD4 surface expression in CEM-T4); blue is CEM-T4 cells co-cultured with CdCl2 treated N5 cells; red is CEM-T4 cells co-cultured with untreated N5 cells; yellow is CEMT4 cells co-cultured with untreated RAW 264.7 cells; green is CEM-T4 cells co-cultured with CdCl2 treated RAW 264.7 cells. (e) Graphical representation of (c-d) plotting the percent of CEM-T4 cells with a Mean Fluorescence Intensity (MFI) below that of positive control cells (CD4 labeled CEM-T4) from 7 independent flow cytometry experiments for all 4 mixes conditions. Co-culture of CdCl2 treated N5 cells with CEM-T4 cells induces a statistically significant decrease of the MFI of CEM-T4 cells (c, d and E- blue). The graph shows the means (± s.e.m), with a P value <0.001 for all 4 conditions (***)
Percp Cy 5.5 Mouse Anti Human Cd4 (Cat # Bdb560650), supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/percp-cy 5.5 mouse anti-human cd4 (cat # bdb560650)/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
percp-cy 5.5 mouse anti-human cd4 (cat # bdb560650) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Becton Dickinson percp/cy 5.5-labeled anti-human cd4
CEM-T4 were mixed in a 1 to 3 ratio with Raw 264.7 cells (± CdCl2) as controls and compared to mixes with CEM-T4 and N5 (± CdCl2). The mixed population of cells were analyzed by flow cytometry for cell surface <t>CD4</t> staining. Representative 2-D scatter plots of the CD4 fluorescence intensity (log scale) in CEM-T4 mixed with N5 (red) vs Raw 264.7 (black) not-treated (a) or treated with CdCl2 for 24 h (b). A downward shift in CD4 fluorescence can be observed between N5 vs Raw 264.7 treated with CdCl2. Representative Cumulative Distribution Function (CDF) (c) and histogram (d) graphs of fluorescence intensity of CD4 (log scale) in CEM-T4 in response to the various co-cultures are plotted. Black line is CD4 negative control (CD4 unlabeled CEM-T4); black dotted line is <t>CD4</t> <t>positive</t> control (CD4 labeled CEM-T4); gray is CEM-T4 transfected with Nef-GFP (control to look at the effect of Nef expression on CD4 surface expression in CEM-T4); blue is CEM-T4 cells co-cultured with CdCl2 treated N5 cells; red is CEM-T4 cells co-cultured with untreated N5 cells; yellow is CEMT4 cells co-cultured with untreated RAW 264.7 cells; green is CEM-T4 cells co-cultured with CdCl2 treated RAW 264.7 cells. (e) Graphical representation of (c-d) plotting the percent of CEM-T4 cells with a Mean Fluorescence Intensity (MFI) below that of positive control cells (CD4 labeled CEM-T4) from 7 independent flow cytometry experiments for all 4 mixes conditions. Co-culture of CdCl2 treated N5 cells with CEM-T4 cells induces a statistically significant decrease of the MFI of CEM-T4 cells (c, d and E- blue). The graph shows the means (± s.e.m), with a P value <0.001 for all 4 conditions (***)
Percp/Cy 5.5 Labeled Anti Human Cd4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/percp/cy 5.5-labeled anti-human cd4/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
percp/cy 5.5-labeled anti-human cd4 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

N/A
Percp cy5 5 anti human cd4 okt4
  Buy from Supplier

N/A
The GK1 5 antibody reacts with mouse CD4 a 55 kDa protein which acts as a co receptor for the T cell receptor TCR in its interaction with MHC Class II molecules on antigen presenting
  Buy from Supplier

N/A
PERCP CY5 5 ANTI HUMAN CD4 SK3 25 T
  Buy from Supplier

N/A
Anti Hu IL 2 clone 5344 111 is derived from a fusion of Sp2 0 myeloma cells with splenocytes from BALB c mice immunized with recombinant human IL 2 Anti Hu IL 2 clone 5344
  Buy from Supplier




Image Search Results


Intravesical adoptive cellular therapy (ACT) using OT-I T cells delays ovalbumin expressing MB49 tumor cell line (MB49OVA) orthotopic tumor growth. Mice were inoculated with orthotopic MB49OVA tumors. Mice were treated with OT-I cells labeled with CellTrace Violet (CTV) delivered intravesically. (A) After 3 hours of instillation, tumors were collected and analyzed for CTV-labeled OT-I T cells by flow cytometry. (B) Mice with MB49OVA orthotopic tumors were treated with unlabeled OT-I T cells and monitored for tumor growth by ultrasound. ACT-treated mice had a reduction in tumor volume compared with phosphate-buffered saline (PBS)-treated mice and improved survival (C). (D) Tumors were collected on day 60 and analyzed for CD3 + , CD8 + , CD4 + and CD8 + OVA tetramer + T cells by flow cytometry. (E) Representative ultrasound images from mice in each treatment group −2 days prior to treatment and 44 days post-treatment. N=8 per group. Repeated 3 times.

Journal: Journal for Immunotherapy of Cancer

Article Title: Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo

doi: 10.1136/jitc-2020-001673

Figure Lengend Snippet: Intravesical adoptive cellular therapy (ACT) using OT-I T cells delays ovalbumin expressing MB49 tumor cell line (MB49OVA) orthotopic tumor growth. Mice were inoculated with orthotopic MB49OVA tumors. Mice were treated with OT-I cells labeled with CellTrace Violet (CTV) delivered intravesically. (A) After 3 hours of instillation, tumors were collected and analyzed for CTV-labeled OT-I T cells by flow cytometry. (B) Mice with MB49OVA orthotopic tumors were treated with unlabeled OT-I T cells and monitored for tumor growth by ultrasound. ACT-treated mice had a reduction in tumor volume compared with phosphate-buffered saline (PBS)-treated mice and improved survival (C). (D) Tumors were collected on day 60 and analyzed for CD3 + , CD8 + , CD4 + and CD8 + OVA tetramer + T cells by flow cytometry. (E) Representative ultrasound images from mice in each treatment group −2 days prior to treatment and 44 days post-treatment. N=8 per group. Repeated 3 times.

Article Snippet: Samples were washed with flow buffer (1.0 L PBS, 5% heat-inactivated fetal bovine serum, 1 mM EDTA, 0.1% sodium azide) and stained for OVA tetramer (MBL International, Woburn, Massachusetts, catalog# TB5001-1) at 4°C for 20 min in the dark followed by cell surface markers CD3 (catalog# 565643), CD8 (catalog# 558106), CD4 (catalog# 550954), CXCR3 (catalog# 562152) and CD45.1 (catalog# 560578, all from BD Biosciences, San Jose, California, USA) at 4°C for 20 min in the dark.

Techniques: Expressing, Labeling, Flow Cytometry

CEM-T4 were mixed in a 1 to 3 ratio with Raw 264.7 cells (± CdCl2) as controls and compared to mixes with CEM-T4 and N5 (± CdCl2). The mixed population of cells were analyzed by flow cytometry for cell surface CD4 staining. Representative 2-D scatter plots of the CD4 fluorescence intensity (log scale) in CEM-T4 mixed with N5 (red) vs Raw 264.7 (black) not-treated (a) or treated with CdCl2 for 24 h (b). A downward shift in CD4 fluorescence can be observed between N5 vs Raw 264.7 treated with CdCl2. Representative Cumulative Distribution Function (CDF) (c) and histogram (d) graphs of fluorescence intensity of CD4 (log scale) in CEM-T4 in response to the various co-cultures are plotted. Black line is CD4 negative control (CD4 unlabeled CEM-T4); black dotted line is CD4 positive control (CD4 labeled CEM-T4); gray is CEM-T4 transfected with Nef-GFP (control to look at the effect of Nef expression on CD4 surface expression in CEM-T4); blue is CEM-T4 cells co-cultured with CdCl2 treated N5 cells; red is CEM-T4 cells co-cultured with untreated N5 cells; yellow is CEMT4 cells co-cultured with untreated RAW 264.7 cells; green is CEM-T4 cells co-cultured with CdCl2 treated RAW 264.7 cells. (e) Graphical representation of (c-d) plotting the percent of CEM-T4 cells with a Mean Fluorescence Intensity (MFI) below that of positive control cells (CD4 labeled CEM-T4) from 7 independent flow cytometry experiments for all 4 mixes conditions. Co-culture of CdCl2 treated N5 cells with CEM-T4 cells induces a statistically significant decrease of the MFI of CEM-T4 cells (c, d and E- blue). The graph shows the means (± s.e.m), with a P value <0.001 for all 4 conditions (***)

Journal: Journal of Cell Communication and Signaling

Article Title: Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes

doi: 10.1007/s12079-018-0493-z

Figure Lengend Snippet: CEM-T4 were mixed in a 1 to 3 ratio with Raw 264.7 cells (± CdCl2) as controls and compared to mixes with CEM-T4 and N5 (± CdCl2). The mixed population of cells were analyzed by flow cytometry for cell surface CD4 staining. Representative 2-D scatter plots of the CD4 fluorescence intensity (log scale) in CEM-T4 mixed with N5 (red) vs Raw 264.7 (black) not-treated (a) or treated with CdCl2 for 24 h (b). A downward shift in CD4 fluorescence can be observed between N5 vs Raw 264.7 treated with CdCl2. Representative Cumulative Distribution Function (CDF) (c) and histogram (d) graphs of fluorescence intensity of CD4 (log scale) in CEM-T4 in response to the various co-cultures are plotted. Black line is CD4 negative control (CD4 unlabeled CEM-T4); black dotted line is CD4 positive control (CD4 labeled CEM-T4); gray is CEM-T4 transfected with Nef-GFP (control to look at the effect of Nef expression on CD4 surface expression in CEM-T4); blue is CEM-T4 cells co-cultured with CdCl2 treated N5 cells; red is CEM-T4 cells co-cultured with untreated N5 cells; yellow is CEMT4 cells co-cultured with untreated RAW 264.7 cells; green is CEM-T4 cells co-cultured with CdCl2 treated RAW 264.7 cells. (e) Graphical representation of (c-d) plotting the percent of CEM-T4 cells with a Mean Fluorescence Intensity (MFI) below that of positive control cells (CD4 labeled CEM-T4) from 7 independent flow cytometry experiments for all 4 mixes conditions. Co-culture of CdCl2 treated N5 cells with CEM-T4 cells induces a statistically significant decrease of the MFI of CEM-T4 cells (c, d and E- blue). The graph shows the means (± s.e.m), with a P value <0.001 for all 4 conditions (***)

Article Snippet: Aqua-poly mount (Cat # 18606) was purchased from PolySciences, Inc. Rabbit anti-Myo10 (Cat # HPA024223) and rabbit anti-calnexin (Cat # C4731) were purchased from Sigma; Guinea Pig anti-Nef (Cat # APP4963) and PerCP-Cy 5.5 mouse anti-human CD4 (Cat # BDB560650) were purchased from Fisher Scientific; rabbit anti- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Sc-25778), goat anti-rabbit IgG-HRP (sc-2004) and goat anti-guinea pig IgG-HRP (sc-2438) were purchased from Santa Cruz Biotechnology, Inc.; and Pacific blue anti-mouse/human CD11b (Cat #101224) was purchased from Biolegends.

Techniques: Flow Cytometry, Staining, Fluorescence, Negative Control, Positive Control, Labeling, Transfection, Expressing, Cell Culture, Co-Culture Assay

CEM-T4 were mixed in a 1 to 3 ratio with Raw 264.7 cells and incubated for 24 h with the supernatant from Raw 264.7 (± CdCl2) or the supernatant of N5 (± CdCl2). The mixed population of cells were analyzed by flow cytometry for cell surface CD4 staining. Representative 2-D scatter plots of the CD4 fluorescence intensity (log scale) in CEM-T4 mixed with supernatant from N5 (red) vs supernatant from Raw 264.7 (black) not-treated (a) or treated with CdCl2 (b). Representative CDF (c) and histogram (d) views are plotted. Black dashed line is CD4 negative control; black dotted line is CD4 positive control; gray is Nef expression in CEM-T4; blue is CEM-T4 cells co-cultured with the supernatant of CdCl2 treated N5 cells; red is CEM-T4 cells co-cultured with the supernatant of untreated N5 cells; yellow is CEMT4 cells co-cultured with the supernatant of untreated RAW 264.7 cells; green is CEM-T4 cells co-cultured with the supernatant of CdCl2 treated RAW 264.7 cells. (e) Graphical representation of (c-d) plotting the percent of CEM-T4 cells with a Mean Fluorescence Intensity (MFI) below that of positive control cells (CD4 labeled CEM-T4) from 3 independent flow cytometry experiments for all 4 culture conditions. No statistically significant changes of the MFI of CEM-T4 cells were observed under any conditions

Journal: Journal of Cell Communication and Signaling

Article Title: Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes

doi: 10.1007/s12079-018-0493-z

Figure Lengend Snippet: CEM-T4 were mixed in a 1 to 3 ratio with Raw 264.7 cells and incubated for 24 h with the supernatant from Raw 264.7 (± CdCl2) or the supernatant of N5 (± CdCl2). The mixed population of cells were analyzed by flow cytometry for cell surface CD4 staining. Representative 2-D scatter plots of the CD4 fluorescence intensity (log scale) in CEM-T4 mixed with supernatant from N5 (red) vs supernatant from Raw 264.7 (black) not-treated (a) or treated with CdCl2 (b). Representative CDF (c) and histogram (d) views are plotted. Black dashed line is CD4 negative control; black dotted line is CD4 positive control; gray is Nef expression in CEM-T4; blue is CEM-T4 cells co-cultured with the supernatant of CdCl2 treated N5 cells; red is CEM-T4 cells co-cultured with the supernatant of untreated N5 cells; yellow is CEMT4 cells co-cultured with the supernatant of untreated RAW 264.7 cells; green is CEM-T4 cells co-cultured with the supernatant of CdCl2 treated RAW 264.7 cells. (e) Graphical representation of (c-d) plotting the percent of CEM-T4 cells with a Mean Fluorescence Intensity (MFI) below that of positive control cells (CD4 labeled CEM-T4) from 3 independent flow cytometry experiments for all 4 culture conditions. No statistically significant changes of the MFI of CEM-T4 cells were observed under any conditions

Article Snippet: Aqua-poly mount (Cat # 18606) was purchased from PolySciences, Inc. Rabbit anti-Myo10 (Cat # HPA024223) and rabbit anti-calnexin (Cat # C4731) were purchased from Sigma; Guinea Pig anti-Nef (Cat # APP4963) and PerCP-Cy 5.5 mouse anti-human CD4 (Cat # BDB560650) were purchased from Fisher Scientific; rabbit anti- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Sc-25778), goat anti-rabbit IgG-HRP (sc-2004) and goat anti-guinea pig IgG-HRP (sc-2438) were purchased from Santa Cruz Biotechnology, Inc.; and Pacific blue anti-mouse/human CD11b (Cat #101224) was purchased from Biolegends.

Techniques: Incubation, Flow Cytometry, Staining, Fluorescence, Negative Control, Positive Control, Expressing, Cell Culture, Labeling